Related Experiment Video
Updated: Aug 7, 2025
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Local Pentraxin-2 Deficit Is a Feature of Intestinal Fibrosis in Crohn's Disease
Steven Levitte1, Franklin V Peale2, Iny Jhun3
1Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Stanford University, 750 Welch Rd Ste 116, Palo Alto, CA, 94304, USA. slevitte@stanford.edu.
Pentraxin-2 (PTX-2) levels are reduced in the normal bowel of patients with Crohn's disease. Lower PTX-2 in the submucosa may indicate a protective role against intestinal fibrosis and restenosis.
Area of Science:
- Gastroenterology
- Immunology
- Pathology
Background:
- Pentraxin-2 (PTX-2) exhibits antifibrotic properties in idiopathic pulmonary fibrosis.
- Its role in intestinal fibrosis, common in inflammatory bowel disease (IBD), is unknown.
Purpose of the Study:
- To assess PTX-2 expression in fibrostenotic Crohn's disease (FCD).
- To correlate PTX-2 levels with postsurgical restenosis risk.
Main Methods:
- Immunohistochemistry on small bowel resections from FCD patients and controls.
- Comparison of PTX-2 signal in strictured vs. normal segments and surgical margins.
Main Results:
- PTX-2 localizes to submucosal vasculature and perivascular tissue.
- PTX-2 signal is lower in normal bowel of FCD patients compared to controls.
- Lower submucosal PTX-2 correlates with higher risk of postsurgical restenosis.
Conclusions:
- This is the first study analyzing PTX-2 in the intestine.
- Reduced PTX-2 in FCD suggests a potential protective role against intestinal fibrosis.
- Lower PTX-2 levels may predict restenosis after surgery.
More Related Videos
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
09:24Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:23Renewal of Intestinal Stem Cells
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...